A clinical formulation indicated for Neurology. This medication targets the specific pathways associated with severe vascular headaches to provide relief from acute migraine symptoms.
A triptan medication indicated to manage acute migraine attacks and designed to alleviate severe headache pain to support rapid functional recovery.
Mechanism of Action
It stimulates specific serotonin receptors (5-HT1B/1D) on cranial blood vessels, causing them to constrict and blocking the release of inflammatory pain chemicals.
Route of Administration
Oral
Onset Time
30–60 minutes (tablet); 10 minutes (injection)
Duration
Up to 24 hours
Contraindications
Ischemic heart disease, History of stroke, Uncontrolled hypertension, Peripheral vascular disease, Severe liver disease
Severe Adverse Events
Heart attack, Stroke, Serotonin syndrome, Severe cardiovascular events, Seizures
Common Side Effects
Tingling sensation, Dizziness, Flushing, Feeling of heaviness
Information for Sumatriptan is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
